NEOV NeoVolta Inc.

NASDAQ
$2.19

NeoVolta's Revenue Essentially Vanished in Q4 — But the SK On Deal and a $53M Binding Reservation Rewrote the 2027 Story

NeoVolta reported a fiscal fourth-quarter loss of $0.24 per share on revenue of $13,460 — not millions, thousands — against a consensus estimate of -$0.10 per share and $1.38 million in revenue. The company missed consensus earnings by 140.0% and revenue by 99.1%. Earnings fell 380.0% year over year and revenue fell 99.7%. There is no way to soften that: the legacy operating business effectively went to zero in the June quarter, and the sequential path tells the story bluntly — $4.6 million in the second quarter, roughly $2 million in the third, and essentially nothing in the fourth. Full-year revenue of $13.3 million, up 58% from $8.4 million, was earned almost entirely in the first nine months. That is the central tension of this report: the reported quarter was a collapse, while the forward-looking pipeline improved more in the past three months than in the company's entire history.

The quality of the loss deserves scrutiny, and in this case some of it is non-recurring. The $11.7 million GAAP net loss included a $3.9 million provision for credit losses and bad debt and $1.1 million of residential inventory obsolescence reserves — housekeeping tied to an installer channel that broke down after federal tax law changes in early calendar 2026. But even stripping those out, adjusted EBITDA was -$8.0 million in the quarter and -$12.8 million for the year, versus -$0.7 million and -$2.6 million respectively a year earlier. Gross profit turned negative in the quarter on the inventory reserve, after 46% reported gross margin (36% adjusted) in the third quarter. Operating expenses of $9.1 million in a quarter with essentially no revenue reflect a company carrying the cost structure of a manufacturer before the factory produces anything.

The call made clear that management is now running a pre-revenue industrial business, not a residential battery supplier. The Pendergrass, Georgia facility, held through the 80%-owned NeoVolta Power JV (up from 60% earlier in the year), is officially open but still in commissioning and site acceptance testing, with materials procured for only the first 10 units. This is where the credibility problem lives: on the second-quarter call, management targeted July–August production and just under 1 GWh in calendar 2026; the third-quarter call pointed to a third-calendar-quarter ramp. As of late September the line is still being commissioned, with orders expected only by the end of calendar 2026 and production ramp now framed for the second quarter of fiscal 2027. The redesigned C&I product moved from 233 kWh to 313 kWh, pushing first deliveries to February–April 2027 pending certification. Timelines have slipped in each of the past three quarters.

What genuinely changed is the supply and demand architecture. The signed five-year SK On agreement covers 9 GWh of U.S.-manufactured LFP cells from 2027 through 2031, with a framework for another 9 GWh plus SK On purchases of NeoVolta-built packs — up to 18 GWh of combined activity, with the pack purchase agreement targeted within six to eight weeks. Two quarters ago, cell sourcing was described only as conversations. Infinite Grid Capital's roughly 1.1 GWh / $200 million LOI is still non-binding in the main, but approximately $53 million covering the first ~300 MWh for a North Ontario edge AI data center project has converted into a binding capacity reservation — against a sole $1.9 million binding C&I order last quarter. Line 2 has been accelerated, pulling the 8 GWh Pendergrass capacity target into 2028. FEOC compliance opinions on the Pendergrass facility, the NVApex 5MWh BESS and the NVWave residential product support Section 48E eligibility, which matters commercially in a post-incentive-change residential market.

The financing picture is the offsetting risk. Cash, restricted cash and equivalents ended the year at $25.4 million, up from $11.5 million at March 31, following roughly $50 million of equity raised in fiscal 2026 and supplemented after year-end by a $20 million senior secured term loan (less $1.0 million OID) with up to $10 million more available. Shares outstanding went from 34.1 million to 58.3 million. A $200 million shelf filed after the close pressured the stock and is a live dilution overhang, because working capital for the ramp and a second line must be funded well before binding orders convert into cash.

Investor sentiment improved modestly, moving from 0.3558 to 0.4135 — positive and slightly stronger, consistent with investors looking past the June quarter toward Pendergrass rather than reacting to it. The price action tells the same story: shares are up 30.7% since the opening after the prior report and sit 147.1% above the $1.36 52-week low set on May 18, within this inter-earnings window. But the stock is also 22.8% below the $4.35 quarter high reached on August 31 — the day of the SK On announcement — and only 6.2% above its 200-day moving average at $3.16. The market already paid for the partnership and has given back a meaningful portion of that spike.

The bottom line is that NeoVolta reported one of the weakest revenue quarters a public operating company can report while simultaneously assembling the most credible version of its growth case to date. The residential channel has been gutted by incentive changes, margins turned negative on reserves, and the cash burn is accelerating ahead of first production. Everything now depends on execution: commissioning Pendergrass, converting the IGC LOI and the SK On pack framework into binding orders, and funding the ramp without punishing dilution. The catalysts are real and specific, but so is the pattern of slipping timelines — and with the stock still well above its spring lows, investors are paying for a 2027 ramp that has not yet produced a unit.

← Back to NEOV news